Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors
摘要:
A series of novel L-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N(APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC50 = 13.2 mu M) similar with APN inhibitor Bestatin (IC50 = 15.5 mu M), and could be used as lead compound in the future. (C) 2008 Elsevier Ltd. All rights reserved.
A series of novel L-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N(APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC50 = 13.2 mu M) similar with APN inhibitor Bestatin (IC50 = 15.5 mu M), and could be used as lead compound in the future. (C) 2008 Elsevier Ltd. All rights reserved.